{"version":"1.0","provider_name":"Cancer Research Institute","provider_url":"https:\/\/www.cancerresearch.org\/es","title":"First FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy - Cancer Research Institute","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ggP7kjlPxN\"><a href=\"https:\/\/www.cancerresearch.org\/es\/media-room\/fda-approves-provenge-prostate-cancer-vaccine\">First FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cancerresearch.org\/es\/media-room\/fda-approves-provenge-prostate-cancer-vaccine\/embed#?secret=ggP7kjlPxN\" width=\"600\" height=\"338\" title=\"\u00abFirst FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy\u00bb \u2014 Cancer Research Institute\" data-secret=\"ggP7kjlPxN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.cancerresearch.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/af2d4ad3-89dd-41d1-ba1d-95495b414a5c.jpg","thumbnail_width":206,"thumbnail_height":136,"description":"CRI celebrates yesterday&rsquo;s announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food and Drug Administration. The vaccine, called Provenge, is produced by Seattle biotech company Dendreon and is designed to treat certain forms of advanced prostate cancer."}